Nanoparticles as Drug Delivery Systems: A Review of the implication of nanoparticles’ physicochemical properties on responses in biological systems A Yusuf, ARZ Almotairy, H Henidi, OY Alshehri, MS Aldughaim Polymers 15 (7), 1596, 2023 | 134 | 2023 |
Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells MI Fekry, SM Ezzat, MM Salama, OY Alshehri, AM Al-Abd Scientific reports 9 (1), 1746, 2019 | 77 | 2019 |
Viridiflorol induces anti-neoplastic effects on breast, lung, and brain cancer cells through apoptosis MA Akiel, OY Alshehri, SA Aljihani, A Almuaysib, A Bader, AI Al‐Asmari, ... Saudi Journal of Biological Sciences 29 (2), 816-821, 2022 | 13 | 2022 |
Evaluation of the cytotoxic activity of Tamarix articulata and its anticancer potential in prostate cancer cells AM Alnuqaydan, AG Almutary, OY Alshehri, HA Henidi, AM Alajlan, ... Journal of Applied Pharmaceutical Science 12 (02), 089-108, 2022 | 6 | 2022 |
In silico screening and anticancer-apoptotic evaluation of newly synthesized thienopyrimidine/sulfonamide hybrids EI Elmongy, FA Binjubair, OY Alshehri, KA Baeshen, ZA Almukhalfi, ... International Journal of Molecular Sciences 24 (13), 10827, 2023 | 4 | 2023 |
Protective Effect of Fustin against Huntington’s Disease in 3-Nitropropionic Treated Rats via Downregulation of Oxidative Stress and Alteration in Neurotransmitters and Brain … MN Bin-Jumah, SJ Gilani, AF Alabbasi, FA Al-Abbasi, SA AlGhamdi, ... Biomedicines 10 (12), 3021, 2022 | 3 | 2022 |
Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles' Physicochemical Properties on Responses in Biological Systems. A ALMOTAIRY, A Yusuf, H Henidi, O Alshehri, M Aldughaim | 1 | 2023 |
Epicatechin protects from doxorubicin induced cardiotoxicity without affecting its cytotoxic profile in breast cancer cells OY Alshehri, FA Al-Abbasi, HM El-Bassossy, HM Abdallah, AM Al-Abd Cancer Research 76 (14_Supplement), 263-263, 2016 | 1 | 2016 |
Thymoquinone and epicatechin ameliorate the anticancer properties of tafuramycin-A against naïve and resistant breast cancer cells OY Alshehri, HA Henidi, FA Alabbasi, IM El-Deeb, MA Halwani, ... Cancer Research 80 (16_Supplement), 6558-6558, 2020 | | 2020 |
Epicatechin alleviates DOX-induced cardiovascular toxicity and improves its cytotoxic profile against breast cancer cells OY Alshehri, FA Alabbasi, IF Mahmoud, AT Abu-Sharib, HM El-Bassossy, ... Cancer Research 78 (13_Supplement), 4930-4930, 2018 | | 2018 |